Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7099389rdf:typepubmed:Citationlld:pubmed
pubmed-article:7099389lifeskim:mentionsumls-concept:C0205112lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0033371lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0002302lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0282151lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0680727lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:7099389lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:7099389pubmed:issue6lld:pubmed
pubmed-article:7099389pubmed:dateCreated1982-9-24lld:pubmed
pubmed-article:7099389pubmed:abstractTextThe effects of alpha-melanocyte-stimulating hormone (alpha-MSH) on basal and stimulated of prolactin were studied. Intraventricular (i.v.t.) injection of 2 microgram of alpha-MSH in ovariectomized (OVX) rats produced a 50% depression of plasma prolactin levels within 10 min, whereas 100 ng of alpha-MSH or saline had no effect. 2 microgram of alpha-MSH (i.v.t.) produced a more dramatic and sustained depression of prolactin levels if initial prolactin concentrations were elevated. This dose of alpha-MSH was also effective in lowering plasma prolactin levels in OVX rats, primed 72 h earlier with 50 microgram of estradiol benzoate (s.c.), although this depression was of lower relative magnitude than in the unprimed OVX animals. The intravenous injection of a dopamine receptor blocker, spiroperidol (0.1 mg/kg), prior to (i.v.t.) alpha-MSH blocked the inhibitory effect of alpha-MSH on prolactin release. In vitro, alpha-MSH in doses ranging from 0.5 to 5 microgram did not alter prolactin release from hemipituitaries of male or OVX female rates and from dispersed pituitary cells from female rats. These results suggest that alpha-MSH can modulate prolactin release possibly via the hypothalamic dopaminergic system, and that this modulation may be of greater significance during stress.lld:pubmed
pubmed-article:7099389pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:languageenglld:pubmed
pubmed-article:7099389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:citationSubsetIMlld:pubmed
pubmed-article:7099389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7099389pubmed:statusMEDLINElld:pubmed
pubmed-article:7099389pubmed:monthJunlld:pubmed
pubmed-article:7099389pubmed:issn0028-3835lld:pubmed
pubmed-article:7099389pubmed:authorpubmed-author:McCannS MSMlld:pubmed
pubmed-article:7099389pubmed:authorpubmed-author:MizunumaHHlld:pubmed
pubmed-article:7099389pubmed:authorpubmed-author:KhorramOOlld:pubmed
pubmed-article:7099389pubmed:issnTypePrintlld:pubmed
pubmed-article:7099389pubmed:volume34lld:pubmed
pubmed-article:7099389pubmed:ownerNLMlld:pubmed
pubmed-article:7099389pubmed:authorsCompleteYlld:pubmed
pubmed-article:7099389pubmed:pagination433-7lld:pubmed
pubmed-article:7099389pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:meshHeadingpubmed-meshheading:7099389-...lld:pubmed
pubmed-article:7099389pubmed:year1982lld:pubmed
pubmed-article:7099389pubmed:articleTitleEffect of alpha-melanocyte-stimulating hormone on basal and stimulated release of prolactin: evidence for dopaminergic mediation.lld:pubmed
pubmed-article:7099389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7099389pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7099389pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7099389lld:pubmed